Purchase Order 75D30123P18288
- Not listed
- This is a federal purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract, valued at $21,556.49, is for the provision of HIV Performance Panels, which are quality control tools used in clinical laboratories. The contract has a completion date of September 30, 2019 and a firm fixed price pricing type. This...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc. for $24,778.00. The contract is for the delivery of SeraCare bioservices, which include quality control tools, reference materials, controls, reagents, and biological materials to support clinical diagnostics, disease prevention, and health promotion initiatives. LGC Clinical Diagnostics, a foreign-owned, for-profit manufacturer, has been awarded...
- This is a $8,667.00 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical diagnostics products. The contract is for the provision of SeraCare BioServices, which includes quality control tools and reference materials to support clinical laboratories, molecular diagnostics, serology testing, and other applications. LGC Clinical Diagnostics has previously...
- The National Institutes of Health (NIH) Clinical Center awarded a firm fixed-price purchase order valued at $43,810 to LGC Clinical Diagnostics Inc., a clinical diagnostics manufacturer based in Milford, Massachusetts. The contract, awarded on April 6, 2026, with an ultimate completion date of September 30, 2026, carries no set-aside designation. LGC Clinical Diagnostics, a foreign-owned subsidiary registered in SAM.gov since 2004, specializes in manufacturing clinical diagnostic products,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price purchase order to LGC Clinical Diagnostics Inc. for reference materials in the amount of one thousand seven hundred eight dollars and seventy-one cents ($1,708.71). The period of performance is through September 1, 2022. No set aside designation was used for this award. LGC Clinical Diagnostics Inc. will provide the reference materials in support of COVID-19 response efforts. As a foreign owned, for-profit...
- This federal contract award is for the validation of the new Roche Instruments, COBAS 5800 (R) diagnostic equipment to LGC Clinical Diagnostics, Inc., a foreign-owned, for-profit manufacturer of clinical diagnostic products and reference materials. The $18,840.40 firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, with an ultimate completion date of October 2, 2025. The contract does not have a set-aside designation....
- This is a firm fixed price purchase order awarded by the Department of State Bureau of Medical Services to Clinical Diagnostic Laboratories, LLC, a minority-owned, woman-owned small business, for laboratory testing services. The contract has a potential value of three hundred sixty-one thousand, five hundred seventy United States dollars ($361,570.00) and was awarded on July 15, 2020, with a completion date of July 14, 2021. The place of performance is in Vernon Hills, Illinois. No set-aside was...
- This $151,410.00 firm fixed price purchase order was awarded to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing products, by the Centers for Disease Control and Prevention (CDC) out of Pittsburgh, Pennsylvania. The contract is for the delivery of laboratory supplies including CBOT singleplex assays, which are used for disease diagnostic testing. This purchase order is not associated with any larger contract vehicle and does not have a set-aside designation. XCR...
- This is a $1,974,948.75 definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America Holdings (LabCorp), a global life sciences company. The contract is for medical laboratory testing and analysis services, including clinical diagnostics, reference laboratory testing, genetic testing, and specialized medical analyses. The contract does not have a set-aside designation, indicating LabCorp competed in an open market procurement....
- This is a $15,655.00 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Miscellaneous Foreign Awardees, a for-profit foreign organization registered to do business with the U.S. government. The contract is for lab services and does not have a set-aside designation. The contract has an ultimate completion date of July 9, 2024. Miscellaneous Foreign Awardees has experience providing a range of goods and services to U.S. government agencies...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical laboratory products and diagnostics. The contract, valued at $77,990.25, is for the delivery of LAB PANELS with a period of performance through September 29, 2023. LGC Clinical Diagnostics has previously provided a variety of diagnostic testing services, validation testing, laboratory panels, control products, reference materials, reagents, and other supplies to support clinical diagnostics, disease prevention, and health promotion initiatives across multiple U.S. government agencies, including the Department of Health and Human Services. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | $105 | 1/17/25 | |
| P00002 | Other Administrative Action | $0 | 2/28/24 | |
| P00001 | Supplemental Agreement for work within scope | ($105) | 1/26/24 | |
| Not listed | Not listed | $78.0k | 9/25/23 |